Stay updated on Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Only a site revision update from v3.4.1 to v3.4.2 is visible; no changes to study details, eligibility criteria, outcomes, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T05:11:52.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page shows an update from revision v3.4.0 to v3.4.1. The visible content of the trial details remains unchanged.
    Difference
    0.0%
    Check dated 2026-02-07T04:53:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A publication reference for Lebrikizumab efficacy (Ann Allergy Asthma Immunol, 2025, online ahead of print) was added to Publications, and a related citation with Calleja LR was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-31T02:12:31.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a glossary display option; updated QC metadata label to Last Update Submitted that Met QC Criteria and standardized capitalization for No FEAR Act Data; updated the page revision from v3.3.4 to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-23T22:50:28.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added site revision v3.3.4 and removed v3.3.3 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-17T00:32:48.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a new publication entry under Publications: 'Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities' (Ann Allergy Asthma Immunol, 2025) with online ahead of print and DOI information.
    Difference
    0.0%
    Check dated 2025-12-26T16:39:43.000Z thumbnail image

Stay in the know with updates to Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy of Lebrikizumab in Atopic Dermatitis Clinical Trial page.